These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23262097)

  • 1. [The cooperation between p53 and Ras in tumorigenesis].
    Wei YY; Hou J; Tang WR; Luo Y
    Yi Chuan; 2012 Dec; 34(12):1513-21. PubMed ID: 23262097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis.
    Solomon H; Brosh R; Buganim Y; Rotter V
    Discov Med; 2010 May; 9(48):448-54. PubMed ID: 20515613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
    Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
    Barnoud T; Schmidt ML; Donninger H; Clark GJ
    Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs: small but potent oncogenes or tumor suppressors.
    Lee YS; Dutta A
    Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-cadherin and keratinocyte growth factor receptor mediate the functional interplay between Ki-RASG12V and p53V143A in promoting pancreatic cell migration, invasion, and tissue architecture disruption.
    Deramaudt TB; Takaoka M; Upadhyay R; Bowser MJ; Porter J; Lee A; Rhoades B; Johnstone CN; Weissleder R; Hingorani SR; Mahmood U; Rustgi AK
    Mol Cell Biol; 2006 Jun; 26(11):4185-200. PubMed ID: 16705170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotype, ras oncogenes and p53 onco-suppressor gene in benzo(a)pyrene induced malignant soft tissue tumours in Wistar rats.
    Stefanou DG; Nonni AV; Kalpouzos G; Evangelou A; Agnantis NJ
    In Vivo; 1998; 12(5):511-21. PubMed ID: 9827359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells.
    Neault M; Mallette FA; Richard S
    Cell Rep; 2016 Mar; 14(8):1966-78. PubMed ID: 26904954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p21 and p53 expression in gastric cancer.
    Seo YH; Joo YE; Choi SK; Rew JS; Park CS; Kim SJ
    Korean J Intern Med; 2003 Jun; 18(2):98-103. PubMed ID: 12872447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular senescence induced by p53-ras cooperation is independent of p21waf1 in murine embryo fibroblasts.
    Castro ME; del Valle Guijarro M; Moneo V; Carnero A
    J Cell Biochem; 2004 Jun; 92(3):514-24. PubMed ID: 15156563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
    Lin AW; Lowe SW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.
    Chaubert P; Benhattar J; Saraga E; Costa J
    Am J Pathol; 1994 Apr; 144(4):767-75. PubMed ID: 8160776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REDD1, a new Ras oncogenic effector.
    Smith ER; Xu XX
    Cell Cycle; 2009 Mar; 8(5):675-6. PubMed ID: 19242117
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of p53 by ING family members in suppression of tumor initiation and progression.
    Jafarnejad SM; Li G
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):55-73. PubMed ID: 22095030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.
    Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF
    Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cellular senescence by oncogenic RAS.
    Gupta R; Wajapeyee N
    Methods Mol Biol; 2013; 1048():127-33. PubMed ID: 23929102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations.
    Albanese I; Scibetta AG; Migliavacca M; Russo A; Bazan V; Tomasino RM; Colomba P; Tagliavia M; La Farina M
    Biochem Biophys Res Commun; 2004 Dec; 325(3):784-91. PubMed ID: 15541358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.